Trading Signals: SAGE Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)(SAGE Therapeutics Inc)
| SAGE latest price $146.3200 (3.93%) ($140.6500 - $146.9400) on Sat. Nov. 16, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.51% (three month average) | RSI | 54 | Latest Price | $146.3200(3.93%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SAGE advances 1.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support SAGE advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting SAGE price | SAGE will decline at least -1.255% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.255% (StdDev 2.51%) | Hourly BBV | 0 () | Intraday Trend | 3% | | | |
|
5 Day Moving Average | $143.41(2.03%) | 10 Day Moving Average | $142.96(2.35%) | 20 Day Moving Average | $142.06(3%) | To recent high | -14.8% | To recent low | 7.9% | Market Cap | $N/A | | | | SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA. |